Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$583K Buy
3,385
+469
+16% +$76.3K 0.13% 181
2017
Q1
$478K Sell
2,916
-571
-16% -$94.9K 0.13% 176
2016
Q4
$510K Buy
3,487
+1,392
+66% +$209K 0.12% 202
2016
Q3
$350K Buy
2,095
+513
+32% +$86.8K 0.09% 231
2016
Q2
$241K Buy
1,582
+74
+5% +$11.5K 0.06% 286
2016
Q1
$226K Sell
1,508
-185
-11% -$27.5K 0.07% 271
2015
Q4
$275K Buy
1,693
+62
+4% +$9.75K 0.08% 234
2015
Q3
$226K Buy
1,631
+27
+2% +$4.26K 0.07% 264
2015
Q2
$246K Buy
1,604
+480
+43% +$76.9K 0.07% 285
2015
Q1
$180K Sell
1,124
-487
-30% -$76.7K 0.05% 379
2014
Q4
$257K Sell
1,611
-23
-1% -$3.58K 0.05% 363
2014
Q3
$230K Buy
1,634
+79
+5% +$10.3K 0.04% 417
2014
Q2
$184K Sell
1,555
-17
-1% -$1.97K 0.03% 462
2014
Q1
$194K Sell
1,572
-740
-32% -$89.7K 0.04% 440
2013
Q4
$264K Buy
2,312
+675
+41% +$76.8K 0.04% 448
2013
Q3
$183K Sell
1,637
-56
-3% -$6.07K 0.03% 519
2013
Q2
$167K Buy
+1,693
New +$176K 0.03% 510

Other funds holding AMGN

WFG Advisors's AMGN Position: Q2 2017 in Review

WFG Advisors increased its Amgen (AMGN) stake by 16% in Q2 2017, buying an estimated $76.3K and bringing the position to 3,385 shares worth $583K. The position accounts for 0.13% of the portfolio, ranked #181.

WFG Advisors first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • WFG Advisors held 3,385 shares of Amgen worth $583K as of Q2 2017.
  • WFG Advisors bought 469 Amgen shares in Q2 2017, an estimated $76.3K.
  • Amgen made up 0.13% of WFG Advisors's portfolio in Q2 2017, its #181 holding.
  • WFG Advisors first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.